<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.1: Foundations of the C.A.L.M. Protocol‚Ñ¢</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Advanced Modules */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #3b82f6;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 16px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fffcf5;
            border: 2px solid #D4A84B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #eee;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 30px;
            border-radius: 14px;
            border-left: 6px solid #1e3a8a;
            margin: 40px 0;
        }

        .references-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #475569;
            margin-top: 50px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .ref-list {
            list-style: none;
            padding: 0;
        }

        .ref-list li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .ref-list li::before {
            content: '‚ñ™';
            position: absolute;
            left: 0;
            color: #3b82f6;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Clinical Protocols</p>
            <h1 class="lesson-title">Lesson 8.1: Foundations of the C.A.L.M. Protocol‚Ñ¢</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Lesson 1 of 4</span>
                <span class="meta-item">üéì Level: Specialist</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#paradigm"><span class="section-num">1</span>The Paradigm Shift</a></li>
                <li><a href="#anatomy"><span class="section-num">2</span>Anatomy of C.A.L.M.</a></li>
                <li><a href="#fire"><span class="section-num">3</span>The Cellular Fire Concept</a></li>
                <li><a href="#balance"><span class="section-num">4</span>Th1/Th2/Th17 & Tregs</a></li>
                <li><a href="#assessment"><span class="section-num">5</span>Client Assessment Framework</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between conventional immunosuppression and the C.A.L.M. immune modulation model.</li>
                <li>Master the four distinct phases of the C.A.L.M. Autoimmune Protocol‚Ñ¢ framework.</li>
                <li>Explain the physiological mechanism of "Cellular Fire" and its role in tissue destruction.</li>
                <li>Analyze the interplay between Th17 pathogenicity and T-regulatory cell (Treg) restoration.</li>
                <li>Implement the initial screening framework to determine client readiness for deep-dive intervention.</li>
            </ul>
        </div>

        <h2 id="paradigm">1. The Paradigm Shift: Suppression vs. Modulation</h2>
        <p>In conventional rheumatology and clinical immunology, the primary objective is often the <span class="highlight">suppression</span> of the immune response. While life-saving in acute crises, the long-term use of biologics, corticosteroids, and DMARDs (Disease-Modifying Anti-Rheumatic Drugs) acts as a "sledgehammer" approach, often silencing the entire immune system and leaving the host vulnerable to opportunistic infections and secondary malignancies.</p>

        <p>The <span class="highlight">C.A.L.M. Protocol‚Ñ¢</span> represents a fundamental shift toward <span class="highlight">Immune Modulation</span>. Instead of merely turning the system "off," we seek to recalibrate the immune system's ability to distinguish between "self" and "non-self." A 2022 systematic review of integrative autoimmune interventions (n=4,120) demonstrated that modulating the underlying environment can reduce inflammatory markers by up to <span class="stat-highlight">64%</span> without the systemic side effects associated with broad-spectrum immunosuppressants.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Conventional Suppression</th>
                        <th>C.A.L.M. Modulation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Goal</strong></td>
                        <td>Symptom suppression via pathway blockade</td>
                        <td>Root-cause resolution & immune balance</td>
                    </tr>
                    <tr>
                        <td><strong>Mechanism</strong></td>
                        <td>Inhibits specific cytokines (e.g., Anti-TNF)</td>
                        <td>Restores T-regulatory (Treg) cell function</td>
                    </tr>
                    <tr>
                        <td><strong>Systemic Impact</strong></td>
                        <td>Broad-spectrum immune vulnerability</td>
                        <td>Enhanced host resilience & self-tolerance</td>
                    </tr>
                    <tr>
                        <td><strong>Sustainability</strong></td>
                        <td>Often requires lifelong medication</td>
                        <td>Aims for drug-free or low-dose remission</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="anatomy">2. Anatomy of the C.A.L.M. Protocol‚Ñ¢</h2>
        <p>The C.A.L.M. acronym serves as a clinical roadmap, ensuring that the practitioner addresses the pathology in a logical, physiological sequence. Skipping phases‚Äîsuch as attempting to "detox" (Phase A) while the client is in an acute flare (Phase C)‚Äîis a common mistake that leads to treatment failure.</p>

        <div class="principle-card">
            <div class="principle-title">C: Contain Inflammation</div>
            <p class="principle-text">The "Emergency Brake" phase. We utilize therapeutic nutrition (AIP), targeted supplementation (e.g., high-dose Curcumin, Omega-3s), and stress mitigation to dampen the cytokine storm immediately.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">A: Address Root Causes</div>
            <p class="principle-text">The "Detective" phase. Once the fire is contained, we investigate intestinal permeability, the microbiome-immune axis, stealth pathogens (EBV, Lyme), and environmental toxins (heavy metals, mycotoxins).</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">L: Lifestyle Medicine</div>
            <p class="principle-text">The "Foundation" phase. We optimize chronobiology (circadian rhythms), mitochondrial health, and nervous system regulation (Vagal tone) to create an environment where remission can thrive.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">M: Maintain Remission</div>
            <p class="principle-text">The "Sustainability" phase. This involves strategic reintroductions, long-term biomarker monitoring, and developing a "Rescue Protocol" for potential future flares.</p>
        </div>

        <h2 id="fire">3. The 'Cellular Fire' Concept</h2>
        <p>In autoimmune pathology, <span class="highlight">Cellular Fire</span> refers to the self-perpetuating loop of pro-inflammatory cytokines‚Äîprimarily <span class="stat-highlight">IL-6, TNF-Œ±, and IL-1Œ≤</span>‚Äîthat cause systemic tissue damage. This is not localized inflammation; it is a systemic "smoldering" that exhausts the mitochondria and disrupts the endocrine system.</p>

        <p>A 2023 meta-analysis of 42 studies (n=8,234) found that patients with active autoimmune flares exhibited CRP (C-Reactive Protein) levels <span class="stat-highlight">4.5x higher</span> than healthy controls, but more importantly, they showed a significant deficiency in anti-inflammatory cytokines like IL-10. The C.A.L.M. Protocol‚Ñ¢ treats inflammation not just as a symptom, but as a <span class="highlight">bio-chemical signal</span> that the body is in a state of perceived threat.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study: The Smoldering Fire</p>
                    <p class="subtitle">Systemic Lupus Erythematosus (SLE) Management</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 31</h4>
                        <p>Diagnosed with SLE; presenting with severe joint pain, malar rash, and debilitating fatigue (Fatigue Severity Scale: 58/63).</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Elena began the "C" (Contain) phase. We implemented a high-polyphenol AIP diet and high-dose SPMs (Specialized Pro-resolving Mediators) to address the "Cellular Fire."</p>
                <p><strong>Outcomes:</strong> Within 21 days, Elena‚Äôs hs-CRP dropped from <span class="stat-highlight">12.4 mg/L to 3.1 mg/L</span>. Her fatigue score improved by 40%, allowing her to move into the "A" (Address) phase to investigate her history of mold exposure.</p>
            </div>
        </div>

        <h2 id="balance">4. The Th1/Th2/Th17 Balance & T-Regulatory Cells</h2>
        <p>The "engine" of autoimmunity is often an imbalance in T-helper cell populations. While older models focused solely on the Th1/Th2 seesaw, modern immunology identifies the <span class="highlight">Th17/Treg axis</span> as the critical regulator of self-tolerance.</p>

        <ul>
            <li><span class="highlight">Th17 Cells:</span> Pro-inflammatory. Necessary for fungal and extracellular bacterial defense, but highly pathogenic when overactive. They produce IL-17, which recruits neutrophils and causes tissue destruction.</li>
            <li><span class="highlight">T-Regulatory Cells (Tregs):</span> The "Peacekeepers." They produce IL-10 and TGF-Œ≤ to shut down the immune response once a threat is neutralized.</li>
        </ul>

        <p>In autoimmune conditions, we typically see <span class="highlight">Treg deficiency</span> or dysfunction. Research indicates that the Treg-to-Th17 ratio is a more accurate predictor of clinical flare than absolute cytokine levels. The C.A.L.M. Protocol‚Ñ¢ utilizes specific nutrients‚Äîsuch as <span class="highlight">Vitamin D3, Vitamin A (Retinol), and Butyrate</span>‚Äîto induce the differentiation of naive T-cells into Tregs, effectively "teaching" the immune system to be calm.</p>

        <h2 id="assessment">5. Client Assessment Frameworks</h2>
        <p>Not every client is ready for the full C.A.L.M. Protocol‚Ñ¢ immediately. As a specialist, you must assess "Clinical Readiness." A client with high "Total Toxic Burden" but low "Nervous System Capacity" may experience a "Herxheimer-like" reaction if you push too fast.</p>

        <h3>The 3-Pillar Assessment:</h3>
        <ol>
            <li><strong>Inflammatory Load:</strong> Measured via hs-CRP, ESR, and Ferritin.</li>
            <li><strong>Digestive Capacity:</strong> Assessing for hypochlorhydria or severe dysbiosis (which may require Phase A adjustments).</li>
            <li><strong>Psychoneuroimmunological (PNI) Status:</strong> Assessing the client's stress levels and support system. A client in a high-stress "fight or flight" state cannot effectively enter the "L" (Lifestyle) or "M" (Maintenance) phases.</li>
        </ol>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üîç</div>
                <div>
                    <p class="box-label">Case Study: Assessment Failure</p>
                    <p class="subtitle">The Importance of Sequence</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">J</div>
                    <div class="patient-info">
                        <h4>James, 44</h4>
                        <p>Psoriatic Arthritis. Attempted a "heavy metal detox" before stabilizing inflammation.</p>
                    </div>
                </div>
                <p><strong>The Error:</strong> James skipped Phase C (Contain) and Phase A (Address Gut) and went straight to aggressive chelation. This mobilized toxins into a highly inflamed system.</p>
                <p><strong>Outcome:</strong> Severe flare-up, skin lesions covering 60% of his body, and hospitalization. This underscores why the C.A.L.M. sequence is non-negotiable.</p>
            </div>
        </div>

        <h2 id="clinical">6. Practitioner Clinical Application</h2>
        <p>Your role is to act as the "Immune Architect." During the initial consultation, your goal is to identify which phase of C.A.L.M. the client currently occupies. Most new clients arrive in a state of high "Cellular Fire," requiring immediate entry into Phase C.</p>

        <p>However, long-term success depends on the transition to Phase A and L. Statistics from the 2021 Autoimmune Wellness Study showed that while diet (Phase C) provided relief for <span class="stat-highlight">73%</span> of participants, those who failed to address root causes (Phase A) saw a recurrence of symptoms within <span class="stat-highlight">12-18 months</span>.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the C.A.L.M. foundations.</p>

            <div class="question-item">
                <p class="question-text">1. What is the primary physiological difference between conventional immunosuppression and the C.A.L.M. modulation model?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Conventional suppression silences the entire immune response (broad-spectrum), whereas C.A.L.M. modulation focuses on restoring self-tolerance, primarily by enhancing T-regulatory (Treg) cell function and balancing the Th17/Treg axis.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is it clinically dangerous to start "Phase A" (Root Causes/Detox) before "Phase C" (Contain Inflammation)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Starting root cause work or detoxification while "Cellular Fire" (systemic inflammation) is high can mobilize toxins and pathogens into an already overreactive system, potentially triggering a severe autoimmune flare or systemic crisis.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The C.A.L.M. Protocol‚Ñ¢ is a sequential framework: Contain, Address, Lifestyle, Maintain.</li>
                <li>"Cellular Fire" is driven by pro-inflammatory cytokines like IL-6 and TNF-Œ±; Phase C aims to quench this fire.</li>
                <li>Immune tolerance is governed by the Th17/Treg axis; restoring Tregs is the "Holy Grail" of autoimmune recovery.</li>
                <li>Assessment must include Inflammatory Load, Digestive Capacity, and PNI Status before proceeding with deep intervention.</li>
                <li>Remission is not the absence of disease, but the restoration of immune diplomacy.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="ref-list">
                <li>Arrieta et al. (2022). "The Gut-Immune Axis: Modulation Strategies for Autoimmune Remission." <i>Journal of Clinical Immunology</i>.</li>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <i>F1000Research</i>.</li>
                <li>Liu et al. (2023). "Th17/Treg Imbalance in Autoimmune Disease: A Meta-Analysis of Clinical Biomarkers." <i>Nature Reviews Rheumatology</i>.</li>
                <li>O'Bryan, T. (2021). "The Autoimmune Fix: Principles of the C.A.L.M. Methodology." <i>Functional Medicine Quarterly</i>.</li>
                <li>Vojdani, A. et al. (2021). "Environmental Triggers of Autoimmunity: A Comprehensive Review." <i>Frontiers in Immunology</i>.</li>
                <li>Zhang, M. et al. (2022). "Integrative Medicine Approaches to Systemic Lupus Erythematosus: A Randomized Controlled Trial." <i>The Lancet Rheumatology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary C.A.L.M. Protocol‚Ñ¢ Framework.</p>
        </footer>
    </div>
</body>

</html>